E8S-14058-56120
4 vaccinations
11 coded responses
50 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 722 / AR
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: mild soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Vertigo — Feeling: GoodFree text: The afternoon after the shot, mild vertigo and a dry cough. Today, no symptomslMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 21, dose 2MedDRA: Malaise, Pain — Feeling: FairFree text: Malaise, general sorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Cough — Feeling: GoodFree text: Dry cough, infrequentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-10-06
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-06
Survey response — day 0, dose 3MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at the injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-09
-
2021-10-10
Survey response — days 1–6 daily, dose 3MedDRA: Abdominal distension, Pollakiuria — Feeling: Good · Fever · Abdominal painFree text: Bloating and frequent urinationMedDRA releases: 2024-11 · check-in free text available
- 2021-10-11
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
-
2022-01-05
Survey response — 3 months, dose 3MedDRA: Migraine — Feeling: GoodFree text: Low-level migraine headache lasting several weeks, resistant to migraine meds.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-06
-
2022-04-14
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at injection site.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-20
-
2022-04-21
Survey response — day 7, dose 4MedDRA: Sinus congestion — Feeling: FairFree text: Stuffy feeling in sinusesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
-
2022-05-26
Survey response — day 42, dose 4MedDRA: Malaise, Throat irritation — Feeling: FairFree text: Scratchy throat, malaise but no feverMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Survey response — 3 months, dose 4MedDRA: COVID-19, Chills, Cough, Pyrexia, Tremor — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Caught COVID. Fever, chills, shakes, persistent cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-15
-
2022-08-15
Callback requested for02:00PM ET
-
2022-08-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): mild soreness at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): The afternoon after the shot, mild vertigo and a dry cough. Today, no symptomsl
Release 4 — day 21, dose 2
Symptoms: Malaise, general soreness
Release 4 — day 28, dose 2
Symptoms: Dry cough, infrequent
Release 10 — day 0, dose 3
Systemic reaction (other): Soreness at the injection site
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Bloating and frequent urination
Release 10 — 3 months, dose 3
Symptoms: Low-level migraine headache lasting several weeks, resistant to migraine meds.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Soreness at injection site.
Release 11 — day 7, dose 4
Systemic reaction (other): Stuffy feeling in sinuses
Release 11 — day 42, dose 4
Symptoms: Scratchy throat, malaise but no fever
Release 12 — 3 months, dose 4
Symptoms: Caught COVID. Fever, chills, shakes, persistent cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
| SRO | Abdominal distension | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pollakiuria | · | · | ✓ |
| SRO | Sinus congestion | · | · | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release